David Barnett (D.J.M.)

Vliex, L. M. M., Barnett, D., Monzel, E., Nauta, A., Oudhuis, G. J., Fassarella, M., Holst, J. J., Zoetendal, E. G., Penders, J., & Blaak, E. E. (2025). 2'-Fucosyllactose supplementation results in a transient improvement in gut microbial resilience after vancomycin use in adults with overweight or obesity: a randomized, double-blind, placebo-controlled intervention. Gut Microbes, 17(1), Article 2580693. https://doi.org/10.1080/19490976.2025.2580693

Barnett, D., Thijs, C., Mommers, M., Endika, M., Klostermann, C., Schols, H., Smidt, H., Nauta, A., Arts, I., & Penders, J. (2025). Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study. Gut Microbes, 17(1), Article 2485326. https://doi.org/10.1080/19490976.2025.2485326

Verbunt, J., Jocken, J., Canfora, E., Barnett, D., Blaak, E., Savelkoul, P., & Stassen, F. (2025). Assessment of the reproducibility of bacterial membrane vesicle isolation and characterization. Extracellular Vesicles and Circulating Nucleic Acids, 6(4), 728-741. https://doi.org/10.20517/evcna.2025.71

Pyuza, J. J., van Dorst, M. M. A. R., Barnett, D., Stam, K., Manurung, M., Wammes, L., Konig, M., Kruize, Y., Andongolile, N., Ngowi, A., Shao, E. R., Kullaya, V. I., Mremi, A., Hogendoorn, P. C. W., Msuya, S. E., Jochems, S. P., Penders, J., Yazdanbakhsh, M., & Piters, W. A. A. D. S. (2025). Tanzanian gut microbiota profiles linked to high but rapidly waning yellow fever antibody titers. npj Biofilms Microbomes, 11(1), Article 110. https://doi.org/10.1038/s41522-025-00687-w

Endika, M. F., Barnett, D. J. M., Olmos, E. M., Ter Braak, C. J. F., Arts, I. C. W., Penders, J., Nauta, A., Leemhuis, H., Venema, K., & Smidt, H. (2025). Assessing the potential for non-digestible carbohydrates toward mitigating adverse effects of antibiotics on microbiota composition and activity in an in vitro colon model of the weaning infant. FEMS microbiology ecology, 101(4), Article fiaf028. https://doi.org/10.1093/femsec/fiaf028

Hillege, L. E., Barnett, D. J. M., Ziemons, J., Aarnoutse, R., de Vos-Geelen, J., van Geel, R., de Boer, M., van Riet, Y. E. A., Vincent, J., Penders, J., & Smidt, M. L. (2025). The gut microbiota during tamoxifen therapy in patients with breast cancer. Scientific Reports, 15(1), Article 7874. https://doi.org/10.1038/s41598-025-91734-1

Endika, M. F., Barnett, D. J. M., Klostermann, C. E., Kok, N., Schols, H. A., Nauta, A., Arts, I. C. W., Penders, J., Venema, K., & Smidt, H. (2024). Seeding and feeding milestones: the role of human milk microbes and oligosaccharides in the temporal development of infant gut microbiota. Gut Microbiome, 5, Article e7. https://doi.org/10.1017/gmb.2024.5

Ziemons, J., Hillege, L. E., Aarnoutse, R., de Vos-Geelen, J., Valkenburg-van Iersel, L., Mastenbroek, J., van Geel, R., Barnett, D. J. M., Rensen, S. S., van Helvoort, A., Dopheide, L. H. J., Roeselers, G., Penders, J., Smidt, M. L., & Venema, K. (2024). Prebiotic fibre mixtures counteract the manifestation of gut microbial dysbiosis induced by the chemotherapeutic 5-Fluorouracil (5-FU) in a validated in vitro model of the colon. BMC Microbiology, 24(1), Article 222. https://doi.org/10.1186/s12866-024-03384-4

Endika, M. F., Barnett, D. J. M., Klostermann, C. E., Schols, H. A., Arts, I. C. W., Penders, J., Nauta, A., Smidt, H., & Venema, K. (2023). Microbiota-dependent influence of prebiotics on the resilience of infant gut microbiota to amoxicillin/clavulanate perturbation in an in vitro colon model. Frontiers in microbiology, 14(1), Article 1131953. https://doi.org/10.3389/fmicb.2023.1131953